Elise A. Olsen

Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)

Elise A. Olsen, Eric C. Vonderheid, Nicola Pimpinelli et al. · Blood · 2007 · 1.4K citations

Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

Elise A. Olsen, Youn H. Kim, Timothy M. Kuzel et al. · Journal of Clinical Oncology · 2007 · 1K citations

Alopecia areata investigational assessment guidelines–Part II

Elise A. Olsen, Maria K. Hordinsky, Vera H. Price et al. · Journal of the American Academy of Dermatology · 2004 · 764 citations

Ophthalmology, Diagnosis, Clinical Dermatology +3

Finasteride in the treatment of men with androgenetic alopecia

Keith D. Kaufman, Elise A. Olsen, David Whiting et al. · Journal of the American Academy of Dermatology · 1998 · 752 citations

Andrology, Clinical Dermatology, Skin Pharmacology +5

Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer

Elise A. Olsen, Sean Whittaker, Youn H. Kim et al. · Journal of Clinical Oncology · 2011 · 641 citations · Full text

Immunodeficiencies, Immunology, Clinical End Points +17